Clinical Trial Update: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TQ-A3334 in combination with nucleoside analogs as initial therapy for chronic hepatitis B is ongoing. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQ-A3334 (TQ-A3334)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: ACTIVE_NOT_RECRUITING